ArticleDelaware journal of public health2025
Cannabis Use in Adolescents.
Article in Delaware journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adolescent ΔPharmaceuticals (Basel, Switzerland) · 2026Article
- Adolescent Cannabis Use After Cannabis Legalization and the COVID-19 Pandemic.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As cannabis legalization expands across the United States, its use among adolescents remains a pressing public health concern. This analytic essay analyzes the current prevalence, patterns, and consequences of cannabis use in adolescents. While legalization has not substantially increased adolescent use, it has contributed to normalization and greater access, ultimately lowering perceived risk and complicating prevention efforts. Increasing product potency and diversified consumption methods (e.g., vaping, dabbing, edibles) add to these challenges. Adolescent cannabis use is associated with adverse outcomes in brain development, mental health, and physical health including its effects on the gastrointestinal, cardiovascular, respiratory and endocrine systems of body. Cannabis Use Disorder (CUD) is underdiagnosed and undertreated in youth, with no FDA-approved pharmacological treatments. Psychosocial interventions such as contingency management and cognitive behavioral therapy (CBT) show modest efficacy, particularly when involving families. This paper highlights the urgent need for targeted education, policy measures, and accessible evidence-based interventions specifically tailored to adolescent populations to address the evolving challenges of cannabis use and its long-term consequences.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.